Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00106938 · ClinicalTrials.gov registry record · NA
Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I)
A NA study, sponsored by Abbott Medical Devices.
- Terminated
- Registry status
- NA
- Development phase
- 1,663
- Enrollment target
NCT00106938: Clinical Trial NA study, sponsored by Abbott Medical Devices.
NCT00106938 is a NA study that was terminated before completion, run by Abbott Medical Devices. The registered enrollment target is 1,663 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (18% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00106938, a NA study, was terminated before completion, sponsored by Abbott Medical Devices.
- TERMINATED
- Registry status
- NA
- Development phase
- 1,663 participants
- Enrollment target
Study Summary
The study is being conducted to demonstrate the non-inferiority of carotid artery stenting (CAS) using the Emboshield® Embolic Protection System with the Xact® Carotid Stent System to carotid endarterectomy (CEA) for the treatment of asymptomatic extracranial carotid atherosclerotic disease.
Interventions
- DEVICE Carotid artery stenting with filter (interventional)
- PROCEDURE Carotid artery endarterectomy (surgical)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,663 participants |
| Start Date | 2005-04 |
| Est. Completion | 2013-03 |
| Phase | NA |
Why NCT00106938 stopped before completion
NCT00106938 is an interventional study that assigns participants to a tested intervention. Its 1,663 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (18% higher).
The record links to 0 conditions, and to 2 interventions - of which Carotid artery stenting with filter (interventional) is the first listed.
NCT00106938 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00106938 about?
NCT00106938 is a clinical study titled "Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I)". The study is being conducted to demonstrate the non-inferiority of carotid artery stenting (CAS) using the Emboshield® Embolic Protection System with the Xact® Carotid Stent System to carotid endarterectomy (CEA) for the treatment of asymptomatic extracranial carotid atherosclerotic disease.
What is the current status of trial NCT00106938?
This trial is currently terminated. It is a NA study. The enrollment target is 1,663 participants. The study started on 2005-04. Estimated completion is 2013-03.
What interventions are being tested in trial NCT00106938?
The interventions under investigation include: Carotid artery stenting with filter (interventional) (DEVICE), Carotid artery endarterectomy (surgical) (PROCEDURE).
Who is sponsoring clinical trial NCT00106938?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00106938's enrollment target sits among peer trials
1,663 62nd of 2000 higher than 1,939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06034405 · 1,663 participants
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
- NCT06644625 · 1,665 participants
CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
- NCT04852887 · 1,670 participants · Phase 3
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- NCT06401330 · 1,656 participants · Phase 3
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia